🇺🇸 FDA
Pipeline program

SCOUT-Assisted Review Workflow

2025-2702-1

Unknown other active

Quick answer

SCOUT-Assisted Review Workflow for Coronary Heart Disease (CHD) is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Coronary Heart Disease (CHD)
Phase
Unknown
Modality
other
Status
active

Clinical trials